Overview
ADMA market data
Price History
ADMA price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ADMA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Mizuho Maintains Outperform on ADMA Biologics, Lowers Price Target to $17Benzinga · Jul 15, 2026, 6:20 PM
ADMA LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. and Encourages Investors to Contact the FirmGlobenewswire Inc · Jun 17, 2026, 11:15 PM
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)Globenewswire Inc · Jun 11, 2026, 7:15 PM
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug PipelineThe Motley Fool · May 21, 2026, 10:15 PM
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a YearThe Motley Fool · May 21, 2026, 10:15 PM
Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And BiotechBenzinga · May 18, 2026, 2:15 PM
BREAKING: ADMA Biologics Shares Fall Over 24%; Investors Encouraged to Contact Block & Leviton to Possibly Recover LossesGlobenewswire Inc · May 6, 2026, 11:05 PM
8-K filing — ADMA BIOLOGICS, INC. (ADMA)SEC EDGAR · May 6, 2026, 8:10 PM